2-aminoalkyl-5-aminoalkylamino substituted-isoquinoindazole-6(2H

Details 2-aminoalkyl-5-aminoalkylamino substituted-isoquinoindazole-6(2H 2-aminoalkyl-5-aminoalkylamino substituted-isoquinoindazole-6(2H

1994-12-07

1997-02-18

Prior, Kimberly J.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

544125, 544333, 544361, 546 63, 546 64, 546101, 514185, 5142328, 514253, 514398, 514399, 514400, 514406, 514422, 514286, 514287, A61K 31445, C07D23902

Patent

active

056042469

ABSTRACT:
This invention is directed to 2-aminoalkyl-5-aminoalkylamino substituted isoquino[8,7,6-cd]indazole-6-(2H)-ones and to 2-aminoalkyl-5-aminoalkylamino substituted-isoquino[5,6,7-cd]indazole-6(2H)-ones. These compounds have been shown to have antitumor activity.

REFERENCES:
patent: 5447950 (1995-09-01), Patterson
Showalter, et al J. Med. Chem. (1987), 30 pp. 121-131.
Talbot, et al. J. Clin Oncol. (1991), 9(12) pp. 2141-2147.
Campling, et al in Nephrotoxicity, Peter H. Dekker Bach, ed., (New York 1992) pp. 345-352.

Affiliated with

Also associated with

Rating

2-aminoalkyl-5-aminoalkylamino substituted-isoquinoindazole-6(2H does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with 2-aminoalkyl-5-aminoalkylamino substituted-isoquinoindazole-6(2H, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 2-aminoalkyl-5-aminoalkylamino substituted-isoquinoindazole-6(2H will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1602777